Skip to content

PT-141 (bremelanotide)

Peptidespeptide

Availability Prescription

What it is

PT-141, generic name bremelanotide, is a melanocortin receptor agonist and the rare longevity-clinic peptide that is a fully approved drug. FDA approved it in June 2019 as Vyleesi for acquired, generalized hypoactive sexual desire disorder in premenopausal women. It acts in the brain on the pathways that generate desire, not on blood flow the way a PDE5 inhibitor does.

Why people take it

Two very different populations converge on it. One is the labeled group: premenopausal women whose loss of desire is distressing and not explained by a relationship, an illness, or a medication. The other is everyone else, men and postmenopausal women included, drawn by a mechanism that targets wanting rather than mechanics.

How it's delivered

A single-use subcutaneous autoinjector into the abdomen or thigh. The label directs one injection at least 45 minutes before anticipated sexual activity, no more than one dose in 24 hours and no more than eight in a month. Prescribing outside that population is off-label and common, often as a compounded injectable or nasal preparation, which is a different product from the approved one.

Where the evidence stands

Strong inside the indication, thin outside it. Two identical phase 3 trials, the RECONNECT program, randomized 1,267 premenopausal women and found significant improvement in desire and related distress against placebo. The effect was modest: roughly 25 percent of treated women reached the desire threshold versus 17 percent on placebo. Nausea affected about 40 percent, with flushing, headache, and transient blood pressure rises also on the record. For men and postmenopausal women the controlled evidence is earlier-stage, and no regulator has evaluated those uses.

Estimated cost

  • About $930 cash for four Vyleesi autoinjectors, roughly $233 per dose
  • $200–$600/mofor off-label compounded protocols
  • Manufacturer copay assistance can reduce the on-label price sharply
  • On-label prescriptions may be partially covered; off-label use is self-pay

Who offers it

  • ClinicNext Health
  • ClinicCenegenics
  • TelehealthLifeforce
  • TelehealthDefy Medical
  • TelehealthAgelessRx
How we know

Observed in provider menus on our last research pass; each listing is stamped when verified. We may be compensated when you contact providers through Longevity.io; payment never affects ranking.

Go deeper

The Peptide Explorer entry carries the compound record, and the sexual wellness guide separates the approved indication from the much larger off-label market around it.

PT-141 in the Peptide Explorer · Peptides for Sexual Wellness

Longevity.io is for educational purposes only and is not medical advice. Whether bremelanotide belongs in a plan is a conversation for a clinician who knows the whole picture, blood pressure and current medications included. Confirm eligibility, product source, and pricing directly with any provider.

Your Longevity Blueprint

Build your starting plan.

A few short questions, about two minutes. The Blueprint recommends where to start and explains why.

Build my Blueprint